Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/105329

Beta release

Statistics of A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance
Statistics for this year
PeriodVisitsDownloads
202455
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0600
2024-0722
2024-0800